Malar J

Mapping mosquito diversity in Kenya correlating species distribution with malaria prevalence across varied climatic parameters.Zablon JO Goel V Giesbrecht D Kariuki L Mbogo C Goedel WC Bailey JA Matoke-Muhia D
Malar J, (2026). 25:76

Characterizing Plasmodium falciparum genetic diversity and complexity of infections in clinical malaria infections in Western and Coastal Kenya using the poly-alpha microsatellite marker.Abade NA Mgawe C Ndwiga L Kimenyi KM Ochola-Oyier LI
Malar J, (2025). 24:452

African leaders and regional institutions need to take the bull by the horns: a perspective on the impact of the 2025 funding cuts to malaria programmes.Osoro CB Hill J
Malar J, (2025). 25:20

Sociodemographic and ecological factors associated with malaria and malaria recurrence risk in children in Msambweni, Kwale County, Kenya.Amugongo JS LaBeaud AD Bosire C Bisanzio D Nzaro M Ngari M Vu DM Ndenga BA Mutuku FM
Malar J, (2025). 24:433

A scoping review of antimalarial drug resistance markers in Kenya (1987-2022): toward a National Surveillance Framework and Data Repository.Wamae K Magudha J Asiimwe E Kimani K Kandie R Keitany K Snow RW Ochola-Oyier LI
Malar J, (2025). 24:413

Plasma folate dynamics in Plasmodium falciparum-infected African children treated with artemisinin combination therapy and single low-dose primaquine or placebo.Ajayi S Onyamboko MA Olupot-Olupot P Ayuen DS Chimjinda N Taya C Williams TN Uyoga S Maitland K Fanello C Day NPJ Mukaka M Taylor WRJ
Malar J, (2025). 24:342

MALDI-TOF MS for identification of Afro-tropical secondary malaria vectors.Tuwei M Karisa J Wanjiku C Kiuru C Ondieki Z Odongo T Mure F Otieno B Meli P Okoko M Bartilol B Gona R Constantino L Cole G Anastacio T Armazia R Alves C Rui P Ramaita E Rono M Candrinho B Mwangangi J Mbogo C Charlwood D Saute F Rabinovich R Chaccour C Maia MF
Malar J, (2025). 24:284

Phenotypic and genotypic insecticide resistance profiles of main malaria vectors in Kwale county, coastal Kenya.Okoko M Karisa J Gona R Odongo T Otieno B Yaa F Bartilol B Meli P Ondieki Z Tuwei M Wanjiku C Shee F Chaccour C Kiuru C Maia MF
Malar J, (2025). 24:191

Stable Plasmodium falciparum merozoite surface protein-1 allelic diversity despite decreasing parasitaemia in children with multiple malaria infections.Yaa RM Kimenyi KM Palasciano HA Obiero G Ochola-Oyier LI
Malar J, (2025). 24:136

Multiple insecticide resistance in Anopheles funestus from Mopeia, Central Mozambique.Kiuru C Constantino L Cole G Karisa J Wanjiku C Okoko M Candrinho B Saute F Rabinovich NR Chaccour C Maia MF
Malar J, (2025). 24:81

Through the eyes of the participant: using photovoice to understand the experiences and effects of ivermectin MDA in the context of the BOHEMIA clinical trial in Kwale, Kenya.Onyango T Nuru K Kazungu K Wangari W Chaccour C Regina Rabinovich N Mwangangi J Maia M Jones C
Malar J, (2025). 24:79

Comparing HemoCue(R) and Quantitative Buffy Coat(R) and Coulter Counter-measured haemoglobin concentrations in African children with acute uncomplicated malaria: a Bland-Altman analysis.Ayuen DS Olupot-Olupot P Muhindo R Onyamboko MA Ajayi S Chimjinda N Taya C Uyoga S Williams TN Maitland K Fanello C Day NPJ Taylor WR Mukaka M
Malar J, (2025). 24:77

The Anopheles coluzzii range extends into Kenya: detection, insecticide resistance profiles and population genetic structure in relation to conspecific populations in West and Central Africa.Kamau L Bennett KL Ochomo E Herren J Agumba S Otieno S Omoke D Matoke-Muhia D Mburu D Mwangangi J Ramaita E Juma EO Mbogo C Barasa S Miles A
Malar J, (2024). 23:122

A field bioassay for assessing ivermectin bio-efficacy in wild malaria vectors.Ominde KM Kamau Y Karisa J Muturi MN Kiuru C Wanjiku C Babu L Yaah F Tuwei M Musani H Ondieki Z Muriu S Mwangangi J Chaccour C Maia MF
Malar J, (2023). 22:291

Malaria vaccine coverage estimation using age-eligible populations and service user denominators in Kenya.Moturi AK Jalang'o R Cherono A Muchiri SK Snow RW Okiro EA
Malar J, (2023). 22:287

Border malaria: defining the problem to address the challenge of malaria elimination.Li X Snow RW Lindblade K Noor AM Steketee R Rabinovich R Gopinath D Gasimov E Alonso PL
Malar J, (2023). 22:239

Determinants of utilization of malaria preventive measures during pregnancy among women aged 15 to 49 years in Kenya: an analysis of the Malaria Indicator Survey 2020.Mkubwa B Kagura J Chirwa T Ibisomi L Kinyanjui S
Malar J, (2022). 21:398

The use of routine health facility data for micro-stratification of malaria risk in mainland Tanzania.Thawer SG Golumbeanu M Munisi K Aaron S Chacky F Lazaro S Mohamed A Kisoka N Lengeler C Molteni F Ross A Snow RW Pothin E
Malar J, (2022). 21:345

Challenges with adherence to the 'test, treat, and track' malaria case management guideline among prescribers in Ghana.Kolekang AS Afrane Y Apanga S Zurovac D Kwarteng A Afari-Asiedu S Asante KP Danso-Appiah A
Malar J, (2022). 21:332

Malaria attributable fractions with changing transmission intensity: Bayesian latent class vs logistic models.Mwai K Nkumama I Thairu A Mburu J Odera D Kimathi R Nyamako L Tuju J Kinyanjui S Musenge E Osier F
Malar J, (2022). 21:326